Showing results (1201-1210 of 1,211) with videos related to

Sort By:
Pageof 122
JAMA Network Open|May 25, 2023
Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical TrialJeffrey S Berger, Matthew D Neal, Lucy Z Kornblith, et al.
ESC Heart Failure|October 22, 2020
Echocardiographic abnormalities and predictors of mortality in hospitalized COVID-19 patients: the ECHOVID-19 studyMats Christian Højbjerg Lassen, Kristoffer Grundtvig Skaarup, Jannie Nørgaard Lind, et al.
The New England Journal of Medicine|August 26, 2022
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection FractionScott D Solomon, John J V McMurray, Brian Claggett, et al.
European Journal of Heart Failure|September 28, 2020
Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trialsJohn R Teerlink, Rafael Diaz, G Michael Felker, et al.
The New England Journal of Medicine|November 13, 2020
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart FailureJohn R Teerlink, Rafael Diaz, G Michael Felker, et al.
Journal of the American College of Cardiology|March 8, 2023
Virtual Care Team Guided Management of Patients With Heart Failure During HospitalizationAnkeet S Bhatt, Anubodh S Varshney, Alea Moscone, et al.
Circulation|November 19, 2014
Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failureMilton Packer, John J V McMurray, Akshay S Desai, et al.
Cardiovascular Diabetology|May 7, 2026
CVOT Summit Report 2025: advances along the cardiovascular-kidney-metabolic disease continuumOliver Schnell, Arnav Agarwal, Michel Azizi, et al.
European Journal of Heart Failure|May 11, 2024
Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trialScott D Solomon, John W Ostrominski, Muthiah Vaduganathan, et al.
The New England Journal of Medicine|September 3, 2024
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection FractionScott D Solomon, John J V McMurray, Muthiah Vaduganathan, et al.
Pageof 122